{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:05:51Z","timestamp":1794254751223,"version":"4.9.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["AGL2017-88702-C2-2-R"],"award-info":[{"award-number":["AGL2017-88702-C2-2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016036","name":"Health~Holland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016036","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Dutch Research Council","doi-asserted-by":"publisher","award":["Biomed02"],"award-info":[{"award-number":["Biomed02"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017636","name":"Cancer Centre Amsterdam","doi-asserted-by":"publisher","award":["CCA2023-9-93"],"award-info":[{"award-number":["CCA2023-9-93"]}],"id":[{"id":"10.13039\/501100017636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017636","name":"Cancer Centre Amsterdam","doi-asserted-by":"publisher","award":["CCA2021-9-77"],"award-info":[{"award-number":["CCA2021-9-77"]}],"id":[{"id":"10.13039\/501100017636","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.xcrm.2025.102358","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:00:13Z","timestamp":1758081613000},"page":"102358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myeloma"],"prefix":"10.1016","volume":"6","author":[{"given":"Cristina","family":"G\u00f3mez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther E.E.","family":"Drees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique A.J.","family":"van Eijndhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils J.","family":"Groenewegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra A.W.M.","family":"Verkuijlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan R.T.","family":"van Weering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Aparicio-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris A.","family":"Frerichs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie P.M.","family":"Verkleij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie J.","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9e M.","family":"Zijlstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.M.","family":"Groothuis-Oudshoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan R.","family":"de Rooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels W.C.J.","family":"van de Donk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7357-4406","authenticated-orcid":false,"given":"D. Michiel","family":"Pegtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102358_bib1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.xcrm.2025.102358_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13045-020-00911-4","article-title":"Measurable residual disease in multiple myeloma: ready for clinical practice?","volume":"13","author":"Burgos","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2025.102358_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1200\/EDBK_175175","article-title":"Established and Novel Prognostic Biomarkers in Multiple Myeloma","volume":"37","author":"Bustoros","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.xcrm.2025.102358_bib4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1182\/blood.2020010439","article-title":"Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE","volume":"139","author":"San-Miguel","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102358_bib5","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-022-02178-3","article-title":"Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma","volume":"29","author":"Larrayoz","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102358_bib6","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1158\/1078-0432.CCR-21-1059","article-title":"Minimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration","volume":"27","author":"Anderson","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41408-023-00796-9","article-title":"Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma","volume":"13","author":"Mithraprabhu","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.xcrm.2025.102358_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/2159-8290.CD-22-0482","article-title":"MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology","volume":"13","author":"Dutta","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102358_bib9","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1182\/blood-2016-09-742296","article-title":"Prognostic role of circulating exosomal miRNAs in multiple myeloma","volume":"129","author":"Manier","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102358_bib10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1158\/1078-0432.CCR-15-0489","article-title":"A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells","volume":"22","author":"Gull\u00e0","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12121","article-title":"Extracellular vesicle miRNA predict FDG-PET status in patients with classical Hodgkin Lymphoma","volume":"10","author":"Drees","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.xcrm.2025.102358_bib12","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102358_bib13","article-title":"Towards IVDR-compliance by implementing quality control steps in a quantitative extracellular vesicle-miRNA liquid biopsy assay for response monitoring in patients with classic Hodgkin lymphoma","volume":"3","author":"Drees","year":"2024","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.xcrm.2025.102358_bib14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1182\/blood-2017-06-788950","article-title":"Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study","volume":"131","author":"Lindahl","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102358_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41698-022-00262-y","article-title":"A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy","volume":"6","author":"Rajakumar","year":"2022","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2025.102358_bib16","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1097\/SLA.0000000000004993","article-title":"Transcriptomic Profiling Identifies an Exosomal microRNA Signature for Predicting Recurrence Following Surgery in Patients With Pancreatic Ductal Adenocarcinoma","volume":"276","author":"Nishiwada","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xcrm.2025.102358_bib17","article-title":"Reassessment of miRNA variant (isomiRs) composition by small RNA sequencing","volume":"3","author":"G\u00f3mez-Mart\u00edn","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2025.102358_bib18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41587-021-00874-y","article-title":"Quantitative mapping of the cellular small RNA landscape with AQRNA-seq","volume":"39","author":"Hu","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102358_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102645","article-title":"IsoSeek for unbiased and UMI-informed sequencing of miRNAs from low input samples at single-nucleotide resolution","volume":"4","author":"van Eijndhoven","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2025.102358_bib20","doi-asserted-by":"crossref","first-page":"22566","DOI":"10.18632\/oncotarget.8124","article-title":"Noninvasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles","volume":"7","author":"Koppers-Lalic","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2025.102358_bib21","doi-asserted-by":"crossref","first-page":"W372","DOI":"10.1093\/nar\/gkad429","article-title":"NORMSEQ: a tool for evaluation, selection and visualization of RNA-Seq normalization methods","volume":"51","author":"Scheepbouwer","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12302","article-title":"Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA","volume":"12","author":"Bracht","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.xcrm.2025.102358_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.xcrm.2025.102358_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102358_bib25","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nmeth.3968","article-title":"Points of Significance: Model selection and overfitting","volume":"13","author":"Lever","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102358_bib26","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41467-022-28515-1","article-title":"Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma","volume":"13","author":"Ng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102358_bib27","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41419-019-1959-5","article-title":"TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma","volume":"10","author":"Giallongo","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102358_bib28","doi-asserted-by":"crossref","first-page":"D179","DOI":"10.1093\/nar\/gkac884","article-title":"isomiRdb: microRNA expression at isoform resolution","volume":"51","author":"Aparicio-Puerta","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib29","series-title":"bioinfoUGR\/miSRA: miSRA Profiler","author":"Bioinformatics","year":"2024"},{"key":"10.1016\/j.xcrm.2025.102358_bib30","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1038\/s41467-018-05348-5","article-title":"Predicting treatment benefit in multiple myeloma through simulation of alternative treatment effects","volume":"9","author":"Ubels","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102358_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.793040","article-title":"Multiple Myeloma-Derived Extracellular Vesicles Impair Normal Hematopoiesis by Acting on Hematopoietic Stem and Progenitor Cells","volume":"8","author":"Laurenzana","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.xcrm.2025.102358_bib32","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1182\/bloodadvances.2021005772","article-title":"SORT1\/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma","volume":"6","author":"Yamamoto","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2025.102358_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313144","article-title":"A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma","volume":"22","author":"Papanota","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102358_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3324\/haematol.2013.093500","article-title":"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"99","author":"Kubiczkova","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2025.102358_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.trecan.2020.06.003","article-title":"Circulating miRNAs as Biomarkers in Aggressive B Cell Lymphomas","volume":"6","author":"Drees","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.102358_bib36","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ccell.2024.06.003","article-title":"Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution","volume":"42","author":"Casanova-Salas","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102358_bib37","article-title":"Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to Macaca nemestrina","volume":"1","author":"Driedonks","year":"2022","journal-title":"J. Extracell. Biol."},{"key":"10.1016\/j.xcrm.2025.102358_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114211","article-title":"Identification of WNK1 as a therapeutic target to suppress IgH\/MYC expression in multiple myeloma","volume":"43","author":"Ye","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102358_bib39","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1158\/1078-0432.CCR-24-0256","article-title":"MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance","volume":"30","author":"Davis","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ijc.31041","article-title":"MicroRNA-324-5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling","volume":"142","author":"Tang","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102358_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1182\/blood.2021013199","article-title":"Sustained minimal residual disease in myeloma","volume":"139","author":"Bianchi","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2025.102358_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ni.3385","article-title":"The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity","volume":"17","author":"Gonzalez-Martin","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102358_bib43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/eji.202048993","article-title":"miR-148a controls metabolic programming and survival of mature CD19-negative plasma cells in mice","volume":"51","author":"Pracht","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102358_bib44","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2025.102358_bib45","doi-asserted-by":"crossref","first-page":"W710","DOI":"10.1093\/nar\/gkac363","article-title":"sRNAbench and sRNAtoolbox 2022 update: accurate miRNA and sncRNA profiling for model and non-model organisms","volume":"50","author":"Aparicio-Puerta","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib46","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gkab1101","article-title":"MirGeneDB 2.1: toward a complete sampling of all major animal phyla","volume":"50","author":"Fromm","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib47","doi-asserted-by":"crossref","first-page":"W262","DOI":"10.1093\/nar\/gkaa452","article-title":"mirnaQC: a webserver for comparative quality control of miRNA-seq data","volume":"48","author":"Aparicio-Puerta","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib48","article-title":"ComBat-seq: batch effect adjustment for RNA-seq count data","volume":"2","author":"Zhang","year":"2020","journal-title":"NAR Genom. Bioinform."},{"key":"10.1016\/j.xcrm.2025.102358_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14806\/ej.17.1.200","article-title":"Cutadapt removes adapter sequences from high-throughput sequencing reads","volume":"17","author":"Martin","year":"2011","journal-title":"EMBnet. j."},{"key":"10.1016\/j.xcrm.2025.102358_bib50","unstructured":"Andrews, S. FastQC: A Quality Control Tool for High Throughput Sequence Data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"10.1016\/j.xcrm.2025.102358_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1101\/gr.209601.116","article-title":"UMI-tools: Modelling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy","volume":"27","author":"Smith","year":"2017","journal-title":"Genome Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102358_bib53","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1158\/1078-0432.CCR-23-4097","article-title":"Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development","volume":"30","author":"Massaro","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib54","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.molcel.2019.05.014","article-title":"3\u2032 Uridylation Confers miRNAs with Non-canonical Target Repertoires","volume":"75","author":"Yang","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102358_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.xcrm.2025.102358_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.102358_bib57","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gkab297","article-title":"miRTargetLink 2.0\u2014interactive miRNA target gene and target pathway networks","volume":"49","author":"Kern","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102358_bib58","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat. Biotechnol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125004318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:11:30Z","timestamp":1788563490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125004318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2666379125004318"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102358","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating extracellular vesicle isomiR signatures predict therapy response in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102358","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102358"}}